Search results
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares
GuruFocus.com via Yahoo Finance· 3 months agoArrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CFO Kenneth Myszkowski sold 40,000 shares of the...
Arrowhead Pharmaceuticals Inc Reports Fiscal 2023 Year-End Results
GuruFocus.com via Yahoo Finance· 7 months agoArrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced a net loss of $205.3 million for the fiscal...
Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ...
GuruFocus.com via Yahoo Finance· 4 months agoRevenue: Arrowhead Pharmaceuticals Inc reported a significant decrease in revenue to $3.55 million...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript February 6, 2024...
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Arrowhead Pharmaceuticals fair value...
Insider Sell: CEO Christopher Anzalone Sells 57,755 Shares of Arrowhead Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 9 months agoOn September 18, 2023, Christopher Anzalone, the CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR),...
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) recent 4.3% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) should be aware of the most powerful...
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR)...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares Climb 25% But Its Business Is Yet to Catch Up
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shares would be relieved that the share...